Population pharmacokinetic modeling of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab (Avastin®) in patients with advanced non-squamous non-small cell lung cancer

被引：0
|
作者：
Cheryl S. W. Li
Kevin Sweeney
Carol Cronenberger
机构：
[1] Pfizer Global Product Development,Clinical Pharmacology/Pharmacometrics
[2] Pfizer Inc.,Clinical Pharmacology/Pharmacometrics
[3] Pfizer Global Product Development,Clinical Pharmacology/Pharmacometrics
[4] Pfizer Inc.,undefined
[5] Pfizer Global Product Development,undefined
[6] Pfizer Inc.,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 85卷
关键词：
Bevacizumab; Biosimilar; Non-small cell lung cancer; PF-06439535; Population pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：487 / 499
页数：12
相关论文
共 50 条
  • [11] Efficacy and safety of bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer (NSCLC)
    Tassinari, D.
    Drudi, F.
    Carloni, F.
    Nicoletti, S.
    Possenti, C.
    Santelmo, C.
    Lazzari, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [12] THE EFFICACY AND TOXICITY OF CHEMOTHERAPY WITH BEVACIZUMAB FOR PREVIOUSLY TREATED PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Itotani, R.
    Kitajima, T.
    Inoue, D.
    Takamatsu, K.
    Ishitoko, M.
    Marumo, S.
    Sakuramoto, M.
    Fukui, M.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S47 - S47
  • [13] Bevacizumab Concomitant with Chemotherapy is Effective in Treating Chinese Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer
    Sun, Jing
    Hu, Yi
    Wu, Bai-Shou
    Wang, Jin-Liang
    Tao, Hai-Tao
    Zhang, Su-Jie
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (14) : 5945 - 5950
  • [14] Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study
    Zhao, Zhiting
    Zhao, Luqing
    Xia, Guohao
    Lu, Jianwei
    Shen, Bo
    Zhou, Guoren
    Wu, Fenglei
    Hu, Xiao
    Feng, Jifeng
    Yu, Shaorong
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [15] A FEASIBILITY STUDY OF VINORELBINE AND BEVACIZUMAB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Kaburaki, Kyohei
    Isobe, Kazutoshi
    Yamamoto, Ai
    Tochigi, Naobumi
    Hata, Yoshinobu
    Shibuya, Kazutoshi
    Iyoda, Akira
    Homma, Sakae
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S887 - S887
  • [16] A prospective cohort study of patients with non-squamous non-small cell lung cancer treated with bevacizumab
    Naoki, Katsuhiko
    Takeda, Yuichiro
    Soejima, Kenzo
    Arai, Daisuke
    Naka, Go
    Nagase, Seisuke
    Arirnura, Ken
    Kanemura, Toshinori
    Ohhira, Tatsuo
    Ikeda, Norihiko
    ONCOLOGY LETTERS, 2017, 13 (05) : 3285 - 3290
  • [17] A PROSPECTIVE COHORT STUDY OF NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH BEVACIZUMAB
    Naoki, Katsuhiko
    Soejima, Kenzo
    Nagase, Seisuke
    Kanemura, Toshinori
    Ohhira, Tatsuo
    Takeda, Yuichiro
    Ikeda, Norihiko
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S868 - S868
  • [18] Comparison of efficacy and safety of bevacizumab biosimilar and original bevacizumab in non-squamous non-small cell lung cancer: a systematic review and meta-analysis
    Xiao, Xian
    Zhang, Guixing
    Wang, Chaoran
    Wang, Xiaoqun
    Kong, Fanming
    Jia, Yingjie
    Binxu, Sun
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (06) : 1472 - +
  • [19] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung Cancer
    Guarino, Michael J.
    Masters, Gregory A.
    Biggs, David D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698
  • [20] Bevacizumab in the Treatment of Advanced, Non-Squamous Non-Small Cell Lung Cancer: An Evidence-Based Approach
    Tassinari, Davide
    Sartori, Sergio
    Papi, Maximilian
    Drudi, Fabrizio
    Castellani, Cinzia
    Carloni, Federica
    Tombesi, Paola
    Lazzari-Agli, Luigi
    ONCOLOGY, 2011, 80 (5-6) : 350 - 358
12345